Longval Featured in Msp/St. Paul Business Journal

January 6, 2022

Intricon CEO Scott Longval Featured in 2021 Minneapolis St. Paul Business Journal Book of Lists

Innovation Leader Shares Insights In Annual Business Overview

As he looked ahead to 2022, CEO Scott Longval reflected on the effects of COVID of Intricon Corporation (NASDAQ: IIN) for Minneapolis/St. Paul Business Journal, which highlighted his remarks in its 2021 Book of Lists. The Book of Lists is a primary directory of rankings of top companies located in the Twin Cities. Intricon is listed as a top publicly held company.

Asked about the challenges and turmoil of the past year, Longval zeroed in on an important source of inspiration. He noted the dedication of the Intricon team, commenting specifically on how the company worked to support its forward-thinking mission.

“The past 18 months have been challenging on many fronts—mentally, physically, home life, work life, etc. It’s been very inspiring to watch the team rally together to support our mission to improve, extend and save lives by advancing innovative micromedical technologies through joint development and manufacturing partnerships.”

Intricon enters 2022 uniquely positioned to continue building on its expertise in medical device innovation, from R&D through process development and manufacturing. Focus areas include:

State-of-the-art manufacturing facilities are based in Minnesota and Southeast Asia, all ISO 13485-2016 certified and most registered with the FDA. A proven Design for Manufacturing (DFM) approach pairs premium quality with maximum efficiency to accelerate project timelines, enhance performance, provide higher yields, and improve the cost structure of manufacturing processes.